Mannatech (NASDAQ:MTEX) Shares Pass Below Two Hundred Day Moving Average – What’s Next?

Shares of Mannatech, Incorporated (NASDAQ:MTEX) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $8.75 and traded as low as $7.19. Mannatech shares last traded at $7.40, with a volume of 7,914 shares changing hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Mannatech in a research note on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

Mannatech Price Performance

The company has a current ratio of 1.13, a quick ratio of 0.56 and a debt-to-equity ratio of 0.48. The stock has a fifty day simple moving average of $8.65 and a two-hundred day simple moving average of $8.75. The company has a market cap of $14.06 million, a PE ratio of -8.60 and a beta of 0.79.

Mannatech (NASDAQ:MTEX) last issued its earnings results on Wednesday, November 12th. The company reported $1.01 earnings per share (EPS) for the quarter. The business had revenue of $29.16 million during the quarter. Mannatech had a negative return on equity of 22.75% and a negative net margin of 1.50%.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.